Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hyperthermia × Consolidation Chemotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 12 Leukemia, Myeloid, Acute 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Leukemia 2 Thrombocythemia, Essential 1 Radiation Injuries 1 Primary Myelofibrosis 1 Postoperative Complications 1 Polycythemia Vera 1 Neoplasms 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Lymphoma, B-Cell 1 Low Anterior Resection Syndrome 1 Leukemia, Myelomonocytic, Chronic 1 Hyperthermia 1 Fatigue 1 Esophageal Squamous Cell Carcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Diathermy 18 Radiotherapy 10 Drug Therapy 5 Cisplatin 5 Radiation 3 Melphalan 3 Immune Checkpoint Inhibitors 3 Fluorouracil 3 Cytoreduction Surgical Procedures 3 Brachytherapy 3 tislelizumab 2 Surgical Procedures, Operative 2 Immunotherapy 2 Doxorubicin 2 Conization 2 spartalizumab 1 sodium thiosulfate 1 anlotinib 1 Therapeutics 1 Solutions 1 Radiation Dose Hypofractionation 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Mitomycin 1 Leucovorin 1 Laser Therapy 1 Laparotomy 1 Ifosfamide 1 Hyperthermic Intraperitoneal Chemotherapy 1 Hyperthermia, Induced 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06831981 2025-02-18

ARO 2024-13

University Hospital Tuebingen

Phase NA Recruiting

Gastrointestinal

Hyperthermia, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡